Will These 5 Medical Stocks Surpass Q2 Earnings Forecasts?
Earnings Preview: Pfizer (PFE) Q2 Earnings Expected to Decline
These 4 Measures Indicate That AbbVie (NYSE:ABBV) Is Using Debt Reasonably Well
Piper Sandler Maintains AbbVie(ABBV.US) With Buy Rating, Maintains Target Price $190
AbbVie Says Canada's Drug Agency Has Issued Its First-Ever Time-limited Reimbursement Recommendation For EPKINLY (Epcoritamab)
Express News | Abbvie: Completed Negotiations With Pan-Canadian Pharmaceutical Alliance and a Loi Has Been Signed by Both Parties
Express News | Abbvie's Epkinly™ Receives First-Ever Time-Limited Reimbursement Recommendation by Canada's Drug Agency
Piper Sandler Sticks to Its Buy Rating for AbbVie (ABBV)
Cerevel Therapeutics Gains as Investors Appear More Confident on FTC Approval for AbbVie
US Equities End Higher Monday as Markets Await Corporate Earnings
Equity Markets Rise Intraday as Investors Await This Week's Major Earnings
AbbVie Could Soar 24%, According to a Wall Street Analyst. Is the High-Yield Dividend Stock a Buy Now?
First Full Week of Q2 Earnings, PCE Out Friday
AbbVie (ABBV) Stock Before Q2 Earnings: To Buy or Not to Buy?
Stocks Gain Pre-Bell as Biden Drops Presidential Bid; Asia Down, Europe Rises
AbbVie (ABBV) Fell as Its Arthritis Drug Went Off Patent
Trump Media, CrowdStrike, Tesla, Verizon, Ryanair, and More Stock Market Movers
Kamala Harris' Potential Impact on Health Care Stocks
Here Are Big Pharma's Leading Blockbuster Makers
What to Expect in the Week Ahead (Google and Tesla Earnings; GDP and PCE Data)